Jazz Pharmaceuticals, Inc. v. Becerra

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA _________________________________________ ) JAZZ PHARMACEUTICALS, INC., ) ) Plaintiff, ) ) v. ) ) XAVIER BECERRA, et al., ) ) Case No. 23-cv-01819 (APM) Defendants, ) ) and ) ) AVADEL CNS PHARMACEUTICALS, LLC, ) ) Defendant-Intervenor. ) _________________________________________ ) MEMORANDUM OPINION I. INTRODUCTION The Orphan Drug Act (“ODA”) encourages pharmaceutical companies to develop drugs to treat rare diseases or conditions through various economic incentives, including marketing exclusivity for seven years upon final approval…